Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-169-9 | CAS number: 305-84-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute Toxicity oral, mouse: LD50> 14930 mg/kg bw
Acute toxicity, intravenous administration, rat: LD50 > 2000 mg/kg bw, no adverse effect observed after administration of doses up to 2000 mg/kg bw (Please refer to study entry: acute toxicity: other routes (WoE_AT_rat_RL2))
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1974
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: study meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- - Principle of test:
Acute oral toxicity of the test substance was tested after single oral administration at doses up to 15000 mg/kg bw in mice
- Parameters analysed / observed: death and clinical signs of toxicity - GLP compliance:
- no
- Species:
- mouse
- Strain:
- other: dd strain mice
- Sex:
- male
- Route of administration:
- oral: unspecified
- Vehicle:
- other: physiological saline
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: physiological saline
- Amount of vehicle: 0.1 - 0.3 mL/10 g
- Doses:
- up to 15000 mg/kg bw (other doses were used, but not specified)
- No. of animals per sex per dose:
- 10
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: not specified at least 72 hours
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 14 930 mg/kg bw
- Based on:
- test mat.
- Mortality:
- One out of 10 animals died after 12 hours
- Clinical signs:
- other: No effects observed.
- Interpretation of results:
- other: no classification required according to Regulation (EC) 1272/2008.
- Conclusions:
- Under the condition of the acute toxicity test with the test substance one out of 10 mice died at a dose of 15000 mg/kg bw administered orally.
The available data on acute oral toxicity of the test substance do not indicate requirement of classification according to Regulation (EC) 1272/2008. - Executive summary:
Acute oral toxicity of the test substance was investigated at doses up to 15000 mg/kg bw in groups of ten male dd strain mice. Following oral administration death or other clinical signs of toxicity were determined. The observation period was at least 72 hours. One out of 10 animals died after 12 hours. A LD50 > 14930 mg/kg bw was computed by the Van der Waerden method based on the number of dead mice after 72 hours. No clinical signs of toxicity were observed. Under the condition of the acute toxicity test with the test substance one out of 10 mice died at a dose of 15000 mg/kg bw administered orally. The available data on acute oral toxicity of the test substance do not indicate requirement of classification according to Regulation (EC) 1272/2008.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- The available information comprises two adequate and reliable studies, and is thus sufficient to fulfil the standard information requirements set out in Annex VII, 8.5, of Regulation (EC) No 1907/2006.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute oral toxicity, mouse
Acute oral toxicity of the test substance was investigated at doses up to 15000 mg/kg bw in groups of ten male dd strain mice. Following oral administration death or other clinical signs of toxicity were determined. The observation period was at least 72 hours. One out of 10 animals died after 12 hours. A LD50 > 14930 mg/kg bw was computed by the Van der Waerden method based on the number of dead mice after 72 hours. No clinical signs of toxicity were observed. Under the condition of the acute toxicity test with the test substance one out of 10 mice died at a dose of 15000 mg/kg bw administered orally. The available data on acute oral toxicity of the test substance do not indicate requirement of classification according to Regulation (EC) 1272/2008.
Other route, Acute toxicity, intravenous administration, rat
Acute toxicity of the test substance administered intravenously was investigated in male, adult Sprague-Dawley rats. Although the test substance was not administered via the oral route, the data can be used in a weight of evidence approach for acute oral toxicity of the test substance. Since the availability of the test substance via the intravenous route is assumed to be at a maximum of 100%, the data are considered adequate to cover and evaluate the acute oral toxicity of the test substance.
In the study, groups of 12 rats were administered the test substance at doses of 100, 500, 1000, or 2000 mg/kg bw. The rats were observed for a period of 14 days. Daily assessments of systemic signs of toxicity were performed and included measurements of body weight, food consumption, activity, analysis of organ-specific toxicity, histopathological evaluations at the end of the study period (bone marrow, cerebellum, cerebrum, brain stem, hippocampus, heart, lung, liver, and kidney in randomly selected animals) and mortality. No deaths were observed. Furthermore, no clinical signs of toxicity were observed and there was no difference found between control (saline-treated) and test item-treated groups both in body weight change and the amount of food consumption. Administration of the test substance did not induce signs of toxicity in any of the examined organs. Hence, a LD50 greater than 2000 mg/kg bw was determined in this study. The available data on acute toxicity of the test substance do not meet the criteria for classification according to Regulation (EC) 1272/2008. (Please refer to study entry: acute toxicity: other routes (WoE_AT_rat_RL2).
Supporting studies, Acute oral toxicity, rat and mouse with the structural analogue catena-(S) [µ-[Nα-(3-Aminopropionyl)histidinato(2-)-N1,N2,0:Nτ]- zinc], (CAS 107667 -60 -7)
Acute oral toxicity studies in rats (Sprague-Dawley) and mice (ICR mice [Crj:CD-1 (ICR)]) were conducted with the read-across (RA) substance catena-(S) [µ-[Nα-(3-Aminopropionyl)histidinato(2-)-N1,N2,0:Nτ]- zinc], (CAS 107667 -60 -7) and were used as supporting studies.
The RA substance was administered at doses of 0, 4823, 5787, 6944, 8333, 10000 mg/kg bw to rats (one male and one female per dose) and doses of 0, 566, 820, 1189, 1724, 2500 mg/kg bw to mice (one male and one female per dose). During a period of 14 days following administration, the animals were observed daily and individual body weights were recorded prior to dosing on Day 0 and on Days 1, 3, 7, 10 and 14 after dosing.
1, 3, 9 and 10 female mice were found dead at the applied doses of 820, 1189, 1724 and 2500 mg/kg bw, respectively. 3, 9 and 10 male mice were found dead at the applied doses of 1189, 1724 and 2500 mg/kg bw, respectively. Death was observed 4 h to 2 days after oral administration. The LD50 value for mice was calculated to be 1250 - 1350 mg/kg bw.
3, 3, 4 and 7 female rats were found dead at the applied doses of 5787, 6944, 8333 and 10000 mg/kg bw, respectively. 3, 5, 5 and 9 male rats were found dead at the applied doses of 5787, 6944, 8333 and 10000 mg/kg bw, respectively. Death was observed 1 to 5 days after oral administration of the RA substance. The LD50 value for rats was calculated to be 7000 -8500 mg/kg bw. Rats and mice showed a decrease in locomotor activity, ventral posture, crouching, hypothermia and/or respiratory depression after administration of the test substance. The signs disappeared 2 - 4 days after administration in surviving animals. In addition, loose feces and dirtiness of fur following oral dosing were observed in rats, only. These signs disappeared 5 - 6 days later in surviving animals. (Please refer to study entries: acute toxicity: Supporting study_CAS 107667-60-7_AOT_rat_RL2, Supporting study_CAS 107667-60-7_AOT_mouse_RL2)
Under the condition of the acute oral toxicity test with the RA substance zinc-carnosine (CAS 107667 -60 -7), the determined LD50 value for mice meets the criteria for Acute Tox. 4 (H302) according to Regulation (EC) 1272/2008. Adverse effects observed in this study are most likely attributable to the zinc part, since these effects were not observed in studies with the substance for registration and were not considered relevant for classification. This is in line with data on several zinc compounds. For example, death was reported in mice that consumed 1110 mg zinc/kg/day as zinc sulfate in their diet for 13 weeks. The LD50 of zinc ranges from 186 to 623 mg zinc/kg bw/day in rats and mice. Furthermore, mice appear to be more sensitive than rats to the lethal effects of zinc (ATSDR, 2015).
Under the condition of the acute oral toxicity test with the RA substance zinc-carnosine (CAS 107667 -60 -7), the determined LD50 value for rats does not meet the criteria for classification according to Regulation (EC) 1272/2008. This is in line with the other studies summarized with the substance for registration in mice and rats.
Justification for classification or non-classification
Under the condition of the acute oral toxicity test with the substance for registration one out of ten mice died at a dose of 14930 mg/kg bw. In a further study where the test substance was administered to rats intravenously, no adverse effects or death were observed. The available data used in a weight of evidence approach for evaluation of acute oral toxicity of the substance for registration do not meet criteria for classification according to Regulation (EC) 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.